Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
The report gives an in-depth analysis of the key players involved in the rituximab biosimilars market, sponsors manufacturing the drugs, and putting them through trials to get FDA approvals. The companies included in the market are as follows:
Rituximab Biosimilars Market Size
Rituximab Biosimilars Market Trends
Rituximab Biosimilars Market Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The factors stimulating the development of the market are increased government initiatives, optimal biosimilars costs, and a rise in R&D expenditure in biopharmaceutical companies.
Fewer drug approvals, stringent government regulations, and lack of awareness are the suspected reasons for hindering the growth of this market.
Based on the product type, the market is categorised into blitzima and rixathon, among others.
Based on the indication, the market is divided into non-Hodgkin’s Lymphoma, chronic lymphocytic leukaemia, and rheumatoid arthritis, among others.
The distribution channels are hospital-based pharmacies, retail pharmacies, and online pharmacies.
Based on the region, the market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The trade name for rituximab is Rituxan.
Truxima is the biosimilar of the rituximab reference drug.
A biosimilar is a copy of a biologic medicine that is similar, but not identical, to the original drug.
Biosimilars are available at low costs and thus, have the potential to enhance treatment accessibility.
Rituximab and its biosimilars are primarily used to treat rheumatoid arthritis, lymphoma, and leukaemia.
The major companies involved are Innovent Biologics Inc, Gedeon Richter Plc., BioXpress Therapeutics SA, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Sandoz International GmbH (Novartis), Zydus Lifesciences Ltd., Hetero Drugs Limited, Dr Reddy's Laboratories Ltd, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Zenotech Laboratories, Napp Pharmaceuticals Limited, and Mundipharma International Limited, among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124